1. Oxaliplatin-loaded chemically cross-linked hydrogels for prevention of postoperative abdominal adhesion and colorectal cancer therapy
- Author
-
Seung Hyuk Baik, Hyeji Han, Eun Jung Park, Jee Eun Lee, Sung Joo Hwang, Yeji Seo, Youngbae Jeon, and Sharif Md Abuzar
- Subjects
Male ,Colorectal cancer ,medicine.medical_treatment ,Pharmaceutical Science ,Antineoplastic Agents ,Tissue Adhesions ,02 engineering and technology ,030226 pharmacology & pharmacy ,Rats, Sprague-Dawley ,03 medical and health sciences ,chemistry.chemical_compound ,Postoperative Complications ,0302 clinical medicine ,In vivo ,Hyaluronic acid ,medicine ,Animals ,Chemotherapy ,business.industry ,technology, industry, and agriculture ,Cancer ,Hydrogels ,Adhesion ,021001 nanoscience & nanotechnology ,medicine.disease ,Oxaliplatin ,Drug Liberation ,chemistry ,Self-healing hydrogels ,Cancer research ,Colorectal Neoplasms ,Rheology ,0210 nano-technology ,business ,medicine.drug - Abstract
Colorectal cancer (CRC) is the third most commonly diagnosed cancer among both men and women worldwide. New therapeutic strategies involving cytoreductive surgery and intra-peritoneal chemotherapy could lead to a definitive cure in some cases. However, postoperative intra-abdominal adhesion can cause further complications. In this study, hyaluronic acid (HA)- and carboxymethyl cellulose sodium (CMCNa)-based novel cross-linked hydrogels (HC hydrogels) were synthesized and fully characterized. We demonstrated that varied compositions of HA and CMCNa altered the microstructure, rheology, and degradation behavior of hydrogels. Pre-constructed hydrogels were further loaded with oxaliplatin to prevent intra-abdominal adhesion following chemotherapy. Sustained release of oxaliplatin was observed from hydrogels compared that from solutions, which release drugs through diffusion, following the Higuchi and Korsmeyer-Peppas models. Moreover, low adhesion scores in an in vivo SD rat model demonstrated inhibition of intra-peritoneal adhesion in response to HC hydrogels. Therefore, HC hydrogels offer a novel formulation strategy for providing an intra-abdominal anti-adhesion barrier after cytoreductive surgery and intra-peritoneal chemotherapy for CRC treatment.
- Published
- 2019